{"id":337526,"date":"2026-08-13T16:18:14","date_gmt":"2026-08-13T16:18:14","guid":{"rendered":"https:\/\/www.europesays.com\/se\/337526\/"},"modified":"2026-08-13T16:18:14","modified_gmt":"2026-08-13T16:18:14","slug":"affarsvarlden-satter-kop-pa-vitrolife","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/se\/337526\/","title":{"rendered":"Aff\u00e4rsv\u00e4rlden s\u00e4tter k\u00f6p p\u00e5 Vitrolife"},"content":{"rendered":"<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">Aff\u00e4rsv\u00e4rlden s\u00e4tter rekommendationen k\u00f6p p\u00e5 Vitrolife och ser omkring 30 procent uppsida i sitt huvudscenario. Analysen utg\u00e5r fr\u00e5n en v\u00e4rdering p\u00e5 16 g\u00e5nger r\u00f6relseresultatet, ungef\u00e4r i linje med j\u00e4mf\u00f6rbara medicinteknikbolag.\n <\/p>\n<p>Tidningen r\u00e4knar med i stort sett of\u00f6r\u00e4ndrad f\u00f6rs\u00e4ljning 2026 och d\u00e4refter 7 procents \u00e5rlig tillv\u00e4xt, samtidigt som r\u00f6relsemarginalen v\u00e4ntas stiga fr\u00e5n drygt 20 procent i \u00e5r till 23 procent 2028. Effektiviseringar och en mer l\u00f6nsam produktmix har redan st\u00e4rkt marginalerna.\n <\/p>\n<p>Riskerna \u00e4r fr\u00e4mst fortsatt svag tillv\u00e4xt och \u00f6kad konkurrens. En m\u00f6jlig f\u00f6rs\u00e4ljning av huvudkonkurrenten CooperSurgical beskrivs som en joker som kan f\u00e5 b\u00e5de positiva och negativa effekter.<br \/>\n <br class=\"col-start-2\"\/><\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">Samuel Alaei<br \/>\n <br class=\"col-start-2\"\/><br \/>\n Nyhetsbyr\u00e5n Finwire<\/p>\n","protected":false},"excerpt":{"rendered":"Aff\u00e4rsv\u00e4rlden s\u00e4tter rekommendationen k\u00f6p p\u00e5 Vitrolife och ser omkring 30 procent uppsida i sitt huvudscenario. Analysen utg\u00e5r fr\u00e5n&hellip;\n","protected":false},"author":2,"featured_media":337527,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[65],"tags":[72,70,71,34,31,33,32,30,16859],"class_list":["post-337526","post","type-post","status-publish","format-standard","has-post-thumbnail","category-ekonomi","tag-business","tag-economy","tag-ekonomi","tag-se","tag-svenska","tag-sverige","tag-sweden","tag-swedish","tag-vitrolife"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@se\/117089108172161479","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts\/337526","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/comments?post=337526"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts\/337526\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/media\/337527"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/media?parent=337526"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/categories?post=337526"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/tags?post=337526"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}